HealthLynked Corp. (OTCQB: HLYK), a healthcare technology company focused on AI-powered patient engagement, care coordination and provider connectivity, has selected DRCARE247 as its telemedicine partner, according to an announcement by BioMedWire. The partnership will integrate virtual care directly into the HealthLynked mobile application and website, enabling users to move seamlessly from AI-powered health guidance to provider discovery, appointment scheduling, virtual consultations and medical record management within a single platform.
The integration is expected to begin launching in selected geographic regions over the next three months, with subsequent expansion into additional U.S. markets, subject to provider availability and applicable state requirements. This rollout strategy suggests a phased approach that allows HealthLynked to address regulatory and operational considerations while scaling the service.
This development matters because it signals a further convergence of artificial intelligence, telehealth and electronic health records—areas that have historically operated in silos. By embedding telemedicine into its existing ecosystem, HealthLynked aims to reduce friction for patients who currently navigate multiple apps and portals to access virtual care. The company said the integration is expected to work alongside its AI-powered patient assistant and, where clinically appropriate and permitted, may include prescription management as part of virtual consultations. That could position the platform as a more comprehensive destination for non-emergency care, though it also raises questions about clinical oversight and state-by-state prescribing rules.
HealthLynked’s cloud-based platform connects patients with providers for virtual or in-office appointments and consolidates medical records into one secure, accessible location. With AI-driven insights, integrated telehealth services and intelligent patient engagement tools, the company says it empowers patients and providers to coordinate care more effectively while delivering savings on prescriptions and healthcare services. The platform also supports enterprise partnerships, offering scalable solutions to healthcare networks, employers, insurers, accountable care organizations and digital health innovators.
The partnership comes as payers and providers increasingly seek virtual care options that can be integrated into broader care management workflows. For investors, the key question is whether HealthLynked can execute the rollout across diverse state regulatory environments and drive adoption among both patients and providers. The company’s ability to demonstrate meaningful engagement metrics and clinical outcomes will likely determine whether the integration becomes a competitive differentiator or merely another feature in a crowded telehealth market.
For more details, the full press release is available at https://ibn.fm/HVq1Y. The latest news and updates relating to HLYK are available in the company’s newsroom at https://ibn.fm/HLYLK. BioMedWire, a specialized communications platform focused on biotechnology, biomedical sciences and life sciences, is one of more than 75 brands within the Dynamic Brand Portfolio at IBN. The platform provides access to wire solutions through InvestorWire, along with editorial syndication to 5,000+ outlets, press release enhancement, social media distribution and tailored corporate communications solutions. Full terms of use and disclaimers are available at https://www.BioMedWire.com/Disclaimer.
